Annexon, Inc. (ANNX)
NASDAQ: ANNX · Real-Time Price · USD
5.42
-0.19 (-3.39%)
At close: Mar 18, 2026, 4:00 PM EDT
5.45
+0.03 (0.55%)
After-hours: Mar 18, 2026, 7:45 PM EDT
Annexon Market Cap
Annexon has a market cap or net worth of $648.41 million as of March 18, 2026. Its market cap has increased by 147.29% in one year.
Market Cap
648.41M
Enterprise Value
486.63M
1-Year Change
147.29%
Ranking
Category
Stock Price
$5.42
Market Cap Chart
Since July 24, 2020, Annexon's market cap has increased from $639.51M to $648.41M, an increase of 1.39%. That is a compound annual growth rate of 0.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 836.20M | 11.75% |
| Dec 31, 2025 | 748.26M | 36.84% |
| Dec 31, 2024 | 546.82M | 53.75% |
| Dec 29, 2023 | 355.65M | 44.43% |
| Dec 30, 2022 | 246.25M | -44.15% |
| Dec 31, 2021 | 440.93M | -53.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arvinas | 696.54M |
| Gyre Therapeutics | 679.71M |
| Jade Biosciences | 679.58M |
| AgomAb Therapeutics NV | 675.00M |
| Lexicon Pharmaceuticals | 660.94M |
| Alpha Tau Medical | 643.35M |
| Prime Medicine | 637.35M |
| Design Therapeutics | 635.22M |